BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38723203)

  • 1. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
    Mahapatra MK; Kumar R; Kumar M
    Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New chromone derivatives bearing thiazolidine-2,4-dione moiety as potent PTP1B inhibitors: Synthesis and biological activity evaluation.
    Zheng Y; Lu L; Li M; Xu D; Zhang L; Xiong Z; Zhou Y; Li J; Xu X; Zhang K; Xu L
    Bioorg Chem; 2024 Feb; 143():106985. PubMed ID: 38007892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
    Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study.
    Hidalgo-Figueroa S; Estrada-Soto S; Ramírez-Espinosa JJ; Paoli P; Lori G; León-Rivera I; Navarrete-Vázquez G
    Biomed Pharmacother; 2018 Nov; 107():1302-1310. PubMed ID: 30257345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and
    Yang L; Chen F; Gao C; Chen J; Li J; Liu S; Zhang Y; Wang Z; Qian S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):152-164. PubMed ID: 31742469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors.
    Maheshwari N; Karthikeyan C; Bhadada SV; Verma AK; Sahi C; Moorthy NSHN; Trivedi P
    Bioorg Chem; 2019 Nov; 92():103221. PubMed ID: 31499261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.
    Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Varshney K; Gupta AK; Rawat A; Srivastava R; Mishra A; Saxena M; Srivastava AK; Jain S; Saxena AK
    Chem Biol Drug Des; 2019 Jul; 94(1):1378-1389. PubMed ID: 30903642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
    Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
    Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
    Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors.
    Campos-Almazán MI; Flores-Ramos M; Hernández-Campos A; Castillo R; Sierra-Campos E; Torgeson K; Peti W; Valdez-Solana M; Oria-Hernández J; Méndez ST; Castillo-Villanueva A; Jiménez-de Jesús H; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem; 2021 Oct; 48():116418. PubMed ID: 34563877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.